1030674

Robert J. Amato, D.O. — FEI 3005256154

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)